je.st
news
Shire to Combine with Baxalta in Deal Valued at About $32 Billion
2016-01-11 14:23:03| Biotech - Topix.net
Shire Plc agreed to buy Baxalta Inc. for about $32 billion to become the world's biggest maker of so-called orphan drugs for rare diseases. The price includes 0.1482 of Shire's American depositary receipts and $18 in cash for each Baxalta share held, the Dublin-based drugmaker said in a statement.
Tags: deal
billion
combine
valued
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||